One of the hottest tech stocks in the US market at present – which is really saying something – is advertising technology company The Trade Desk.
In the first of a series on Australian biotech success stories, we start with some of the outstanding medical device stocks on the ASX.
Nucleus Wealth has launched an SMA that allows investors to take a stand on diversity
With July coming to a close, it’s time for reporting season – and this year, it’s not going to be pretty.
While more and more Australian investors get comfortable with investing overseas, it’s fair to assume that Latin America is not on most people’s map of the investable universe – “there be dragons,” as the old mariners used to say.
Listed fund managers Janus Henderson (JHG) and Pendal (PDL) share plenty of similarities: they are both predominantly value-style managers, and they both offer funds spanning North America, UK/Europe and Australasia.
Investors are realising that without meaningful technology exposure, their portfolios are missing a major growth driver. However, the difficulty of picking individual stocks should not be under-estimated, with the innovations and business models of many tech stocks hard to grapple with.
The COVID-19 pandemic has begun to bite into the residential property market, with capital city dwelling values falling a cumulative 1.3% over the past two months – but this mild weakening could be just the start of a double-digit decline.
Tim Toohey from Yarra Capital Management speaks to Giselle Roux from The Inside Network for our IN60 series.
INBrief
Henrik Andersson – Apollo Capital
